Skip to content
OpenCapital
Get started

Sanara MedTech Inc. SMTI Nonmonetary Exchange To Acquire Intangible Assets

Nonmonetary Exchange To Acquire Intangible Assets at other companies

Anterix logo
AnterixATEX
$11.1M+468%
MarineMax logo
MarineMaxHZO
$6.17M—
CWA
CWANCWAN
$0-100%
GE Vernova logo
GE VernovaGEV
$31M—
International Business Machines logo
International Business MachinesIBM
$3.83B+83.9%
NTH
NeOnc Technologies Holdings, Inc. Common StockNTHI
$487.5K—

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S2×-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept SMTI:NonmonetaryExchangeToAcquireIntangibleAssets.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s nonmonetary exchange to acquire intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s nonmonetary exchange to acquire intangible assets?
Sanara MedTech Inc. (SMTI) reported nonmonetary exchange to acquire intangible assets of $2.08M in Q1 2025.
What does nonmonetary exchange to acquire intangible assets mean?
Represents the value of intangible assets acquired through non-cash transactions, such as asset swaps or equity exchanges. This provides insight into how the company expands its intellectual property portfolio without utilizing cash reserves.